- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Global University Venturing
Micreos makes space for $37.5m
Exploiting ETH Zurich research, Micreos is working on a clinical platform that enables the targeted killing of unwanted bacteria only.
Oct 1, 2021Zylotech reaches Terminus for acquisition
MIT spinout Zylotech has been acquired by Terminus for an undisclosed amount.
Oct 1, 2021Li-S Energy celebrates market debut
Based on research at Deakin University, Li-S Energy has gone public on the Australian Stock Exchange after raising $25m in its initial public offering.
Sep 30, 2021Daily deal net: September 30, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sep 30, 2021HSU and UC Davis launch tech centre
Humboldt State University has joined forces with UC Davis to create an incubator focused on agtech and biotech companies in northern California.
Sep 30, 2021Tolbert takes trip to URVentures
University of Rochester has rehired Harl Tolbert, currently with Pennsylvania State University, as associate vice-president of URVentures.
Sep 30, 2021Kytopen constructs $30m series A
The Engine has returned once more to back a $30m round for Kytopen, having first invested in the MIT spinout in 2017.
Sep 29, 2021Daily deal net: September 28, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sep 28, 2021EIF backs Central Europe-focused fund
The European Investment Fund will provide half the capital for the $59m i&i Biotech Fund I, which will operate out of the Czech Republic.
Sep 28, 2021Lucid Diagnostics lines up IPO
Case Western Reserve University-linked Lucid Diagnostics is seeking an initial public offering that would net it up to $57.5m.
Sep 28, 2021Garuda gets underway with $72m
Co-founded by Harvard faculty, Garuda has launched with $72m in series A financing to advance blood stem cell therapies.
Sep 24, 2021Featured Content
University Venture Funds: The ListThe definitive list of university venture funds around the worldUniversity Venture Funds: The List
The definitive list of university venture funds around the world
Special ReportCorporate collaboration with universities: How to commercialise innovative researchSpecial Report
Corporate collaboration with universities: How to commercialise innovative research
Beyond the Breakthrough PodcastExplore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?Beyond the Breakthrough Podcast
Explore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


